EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications

Federica Brescia iD, Ioannis Titilas iD, Simona Cacciapuoti, Luca Ronconi iD

Molecules · 2025

DOI: 10.3390/molecules30173537 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von Federica Brescia und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Chemical Sciences, University of Galway, University Road, H91 TK33 Galway, Ireland. Hauptthemen laut MEDLINE: Glycoconjugates, Antineoplastic Agents, Neoplasms, Metals. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Galway, Irish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rapidly proliferating tumor cells exhibit elevated demands for nutrients and energy to support their uncontrolled growth, with glucose serving as a key metabolic substrate. Glucose is transported into cells via facilitated diffusion mediated by glucose transporters (GLUTs), after which it undergoes a series of enzymatic reactions to generate energy. To accommodate their heightened metabolic needs, cancer cells frequently overexpress GLUTs, thereby enhancing glucose uptake. Notably, aerobic glycolysis—commonly referred to as the “Warburg effect”—has been identified as the predominant pathway of glucose metabolism within tumor tissues, even in the presence of adequate oxygen levels. Consequently, the conjugation of chemotherapeutic agents, including metallodrugs, to glucose-mimicking substrates holds significant potential for achieving tumor-specific intracellular drug delivery by exploiting the elevated glucose uptake characteristic of cancer cells. Moreover, in recent years, glycosylation of metal scaffolds has been extended to the development of bioactive metallodrugs for applications other than cancer treatment, such as potential tumor imaging, antiviral, antimicrobial, antiparasitic and anti-neurodegenerative agents. Accordingly, major advancements in the design of metal-based glycoconjugates for medicinal applications are here summarized and critically discussed, focusing on related results and discoveries published subsequently to our previous (2015) review article on the topic.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycoconjugatesAntineoplastic AgentsNeoplasmsMetalsHumansAnimalsGlucoseDrug Delivery Systems

Stichwörter der Autor:innen

Warburg effectantimicrobialsantiviralschemotherapeuticsglycoconjugatesmetallodrugstargeted anticancer chemotherapytumor imagingtumor metabolism

Substanzen

GlycoconjugatesAntineoplastic AgentsMetalsGlucose

Autor:innen und Institutionen

  • School of Biological and Chemical Sciences, University of Galway, University Road, H91 TK33 Galway, Ireland.

ORCID-Profile: Federica Brescia, Ioannis Titilas, Luca Ronconi

Förderung

  • University of Galway
  • Irish Research Council

Zitieren

APA

Brescia, F., Titilas, I., Cacciapuoti, S., & Ronconi, L. (2025). Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications. Molecules. https://doi.org/10.3390/molecules30173537

Vancouver

Brescia F, Titilas I, Cacciapuoti S, Ronconi L. Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications. Molecules. 2025. doi:10.3390/molecules30173537

BibTeX
@article{Brescia2025,
  author = {Brescia, Federica and Titilas, Ioannis and Cacciapuoti, Simona and Ronconi, Luca},
  title = {Recent Advances in the Development of Metal-Glycoconjugates for Medicinal Applications},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30173537}
}
Kostenlos starten →